Show simple item record

dc.contributor.authorXanthos, Theodoros
dc.contributor.authorEkmektzoglou, Konstantinos A.
dc.contributor.authorPapadimitriou, Lila J.
dc.creatorXanthos, Theodoros
dc.date.accessioned2019-02-09T08:11:42Z
dc.date.available2019-02-09T08:11:42Z
dc.date.issued2008-02-29
dc.identifierSCOPUS_ID:38649108471
dc.identifier.issn01675273
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=38649108471&origin=inward
dc.identifier.urihttps://repo.euc.ac.cy/handle/123456789/1744
dc.description.abstractSilent myocardial ischemia (SMI) is a relatively common, yet poorly understood, clinical entity. The most accurate means of detecting SMI and the precise treatment endpoints remain unclear. However, the presence of SMI correlates with the likelihood of future adverse cardiac events. Evidence suggests that patients at high risk of severe cardiac ischemia, even with the absence of symptoms, derive the greatest benefit from an aggressive diagnostic and therapeutic approach. This paper is giving a detailed review of SMI in regards to specific patient subgroups, i.e. populations with diabetes mellitus, hypertension, elderly patients, post-revascularization patients, women, the suggested screening procedures for each subgroup, as well as the emersion of new markers for the selection of high-risk patients for screening.
dc.relation.ispartofInternational Journal of Cardiology
dc.titleReviewing myocardial silent ischemia: Specific patient subgroups
elsevier.identifier.doi10.1016/j.ijcard.2007.04.029
elsevier.identifier.eid2-s2.0-38649108471
elsevier.identifier.piiS016752730700914X
elsevier.identifier.scopusidSCOPUS_ID:38649108471
elsevier.volume124
elsevier.issue.identifier2
elsevier.coverdate2008-02-29
elsevier.coverdisplaydate29 February 2008
elsevier.openaccess0
elsevier.openaccessflagfalse
elsevier.aggregationtypeJournal


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record